ALKS
Alkermes plc · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables):
amplitud de titulares -4.8% ·
flujo de acciones +1.0% ·
nuevas posiciones netas -10.0%
· fórmula
Acumulación concentrada: acciones en aumento entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 8.96K | $359,305 | n/a | n/a |
| Q2 2026 | 121 | +1 | 123.14M | $6.45B | +12 | −10 |
| Q1 2026 | 122 | -3 | 122.08M | $4.29B | +3 | −7 |
| Q4 2025 | 124 | +2 | 142.93M | $4.00B | +3 | n/a |
| Q3 2025 | 20 | -1 | 95.12M | $2.85B | n/a | −2 |
| Q2 2025 | 19 | +2 | 84.64M | $2.42B | +2 | n/a |
| Q1 2025 | 14 | 0 | 39.73M | $1.31B | n/a | n/a |
| Q4 2024 | 14 | 0 | 45.20M | $1.30B | n/a | n/a |
| Q3 2024 | 13 | +2 | 43.42M | $1.22B | +2 | n/a |
| Q2 2024 | 11 | n/a | 42.07M | $1.01B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 27.97M | +0.4% | $839.16M | 0.0% | ▲ Add | 2 | SEC ↗ ×20 |
| 2 | The Vanguard Group ✦ (pasivo) | 18.18M | -1.8% | $545.39M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | T. Rowe Price ✦ | 10.24M | +2.0% | $307.15M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (pasivo) | 8.54M | +4.0% | $256.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | JPMorgan Chase ✦ | 7.86M | n/a | $235.69M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 6 | Renaissance Technologies ✦ | 6.29M | +8.3% | $188.78M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 4.06M | +0.9% | $121.86M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | PRIMECAP Management ✦ | 2.76M | -4.9% | $82.77M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 1.99M | n/a | $59.85M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 10 | Morgan Stanley ✦ | 1.55M | n/a | $46.54M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 11 | Fidelity (FMR) ✦ | 1.30M | +1.4% | $38.86M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 12 | Arrowstreet Capital ✦ | 1.21M | +1070.6% | $36.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 704.83K | +1783.4% | $21.15M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 656.50K | +101.4% | $19.69M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 528.75K | -35.5% | $15.86M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Wellington Management ✦ | 375.19K | -77.9% | $11.26M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 17 | AQR Capital Management ✦ | 372.42K | -17.7% | $11.17M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 18 | Fisher Asset Management ✦ | 322.75K | +10.6% | $9.68M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Millennium Management ✦ | 147.46K | +89.2% | $4.42M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 62.99K | -52.8% | $1.89M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Norges Bank | $53.33M | era 0.0% |
| Marshall Wace | $5.94M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 384 tenedores, 171.47M acciones, $5.79B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 2.03K acc. · $83,455
Officer · 2.03K acc. · $97,652
Officer · 9.00K acc. · $422,874
Officer · 6.91K acc. · $339,967
Officer · 664 acc. · $32,969
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología